140 followers
Protocol for a multicenter, double-blind, randomized, placebo-controlled phase III trial of the inhaled β2-adrenergic receptor agonist salbutamol for transient tachypnea of the newborn (the REFSAL trial) https://t.co/rI8SUwEpIP https://t.co/PfRGdai2E1